PNLIP and prostate carcinoma: More recently, PTL was found to inhibit the growth of prostate cancer cells dose-dependently and reduce prostate cancer cell-osteoclast co-cultures mediated osteoclast formation, suggesting that PTL could reduce prostate cancer related osteolysis (Marino et al., 2019).